INTERRELATION OF METABOLIC SYNDROME COMPONENTS WITH CELL AND VESSEL AGING PARAMETERS

Aim. To study the interrelation of different MS components and parameters of cell and vessel aging.

Material and methods. Totally 136 patients studied with the age 25-75 y. without any signs of CVD or other chronic diseases, not receiving any continuous drug therapy. In all patients the antropometric parameters, BP levels, fasting plasma glucose, HDL cholesterol and triglycerides levels were measured. The PWV measurement was performed by the device SphygmoCor (AtCorMedical, Australia). Telomere length (TL) was measured by PCR.

Results. Multidimensional regression analysis revealed that among all MS risk factors studied only the age (р=0,0003), waist circumference (р=0,0434), systolic BP (р=0,0001), НОМА-IR (р=0,0033), fasting glycemia (р=0,0001) and TL (р=0,0001) are the independent determinants of PWV, and this relation is reversed for TL, but direct — with the other parameters. Independent reversed relation is with TL only for age (р=0,0033) and НОМА-IR (р=0,0027).

Concluson. Arterial hypertension can be named as the main hemodynamic component and impaired carbohydrate metabolism, insulin resistance and obesity as the main non-hemodynamic components of vessel wall rigidity increase and as the main target for therapeutical intervention.

1. Information Bulletin of the WHO, No. 317 March 2013. Russian (Информационный бюллетень ВОЗ, N°317 Март 2013 г).

2. Nilsson PM, Boutouyrie P, Cunha P, et al. Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens 2013; 8: 1517-26.

3. Scuteri A, NajjarSS, Muller DC et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am CollCardiol 2004; 43: 1388-95.

4. Reaven GM. Banting Lecture 1988. The role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.

5. Lilitkarntakul P, Dhaun N, Melville V, et al. Risk factors for metabolic syndrome independently predict arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal comorbidity. Diabetes Care. 2012 Aug; 35 (8): 1774-80.

6. Fyhrquist F, Saijonmaa O, Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol 2013; 10:274-83.

7. Rotar OP, Moguchaya YeV, Kostareva AA, et al. Telomeres: real association with cardiovascular diseases or inflated expectations? Russian medical lead 2012; 34: 4-12. Russian (Ротарь О.П, Могучая Е.В.,Serra V, von Zglinicki T, Lorenz M, et al. Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem 2001; 278: 6824-30.

8. Gardner JP, Li S, Srinivasan SR, et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation 2005; 111: 2171-7.

9. Negami M, Takahashi E, Otsuka H, et al. Prediction of Homeostasis Model Assessment of Insulin Resistance in Japanese Subjects. Tokai J ExpClin Med 2012; 37: 102-6.

10. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30: e47.

11. Boutouyrie P. New techniques for assessing arterial stiffness. Diabetes&Metabolism.2008; 34: 21-6.

12. Strazhesko ID, Akasheva DU, Dudinskaya EN, et al. Vascular ageing: main symptoms and mechanisms. Cardiovascular Therapy and Prevention, 2012; 11 (4): 93-100. Russian (Стражеско И. Д., Акашева Д. У., Дудинская Е.Н. и др. Старение сосудов: основные признаки и механизмы. Кардиоваскулярная терапия и профилактика. 2012; 4: 93-100).

13. Sharpless NE, DePinho RA. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 2007; 8: 703-13.